Global Megaloblastic Anemia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017 - Research and Markets
February 17 2017 - 10:14AM
Business Wire
Research and Markets has announced the addition of the
"Megaloblastic Anemia - Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2017" drug pipelines to their
offering.
Megaloblastic Anemia - Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2017, provides comprehensive insights
about the marketed drugs, drug sales, Phase III pipeline drugs and
their API Manufacturers across the globe.
A key objective of the Megaloblastic Anemia Report is to
understand the market and pipeline status of the drugs around the
Megaloblastic Anemia to explore the generic development
opportunities, licensing opportunities and to gain competitive
advantage on designing pipeline strategies. The Report provides the
historical and forecasted sales of the drugs till 2018.
The Megaloblastic Anemia Report gives insights into patents
providing the patent protection data and marketing exclusivity of
all the drugs across the Megaloblastic Anemia.
While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and
India.
Key Topics Covered:
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Megaloblastic Anemia
7. Phase III Drugs for Megaloblastic Anemia
8. Discontinued Drugs for Megaloblastic Anemia
9. Appendix
For more information about this drug pipelines report visit
http://www.researchandmarkets.com/research/tvgwq9/megaloblastic
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170217005516/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Related Topics: Hematological Drugs